LivaNova (NASDAQ:LIVN) Rating Increased to Strong-Buy at Zacks Research

Zacks Research upgraded shares of LivaNova (NASDAQ:LIVN) from a hold rating to a strong-buy rating in a research note published on Tuesday morning,Zacks.com reports.

A number of other analysts have also commented on LIVN. Barclays boosted their price objective on LivaNova from $73.00 to $76.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Mizuho lifted their target price on LivaNova from $90.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, July 15th. KeyCorp upped their price target on LivaNova from $83.00 to $92.00 and gave the stock an “overweight” rating in a report on Monday, June 22nd. Robert W. Baird lowered their price target on LivaNova from $78.00 to $76.00 and set an “outperform” rating for the company in a research report on Thursday, May 7th. Finally, Freedom Capital raised LivaNova to a “hold” rating in a research report on Tuesday, June 30th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, LivaNova has an average rating of “Moderate Buy” and an average price target of $81.38.

LivaNova Stock Down 2.0%

LivaNova stock opened at $78.27 on Tuesday. The firm has a market capitalization of $4.30 billion, a price-to-earnings ratio of 40.14 and a beta of 0.86. The firm’s fifty day moving average price is $78.00 and its two-hundred day moving average price is $69.36. LivaNova has a 1-year low of $41.01 and a 1-year high of $85.27. The company has a current ratio of 1.33, a quick ratio of 1.11 and a debt-to-equity ratio of 0.24.

LivaNova (NASDAQ:LIVN) last posted its earnings results on Wednesday, May 6th. The company reported $0.98 EPS for the quarter, topping the consensus estimate of $0.85 by $0.13. LivaNova had a net margin of 7.48% and a return on equity of 16.48%. The company had revenue of $362.26 million during the quarter, compared to the consensus estimate of $346.05 million. During the same period in the previous year, the firm posted $0.88 earnings per share. The firm’s revenue for the quarter was up 14.3% on a year-over-year basis. LivaNova has set its FY 2026 guidance at 4.200-4.300 EPS. On average, equities research analysts predict that LivaNova will post 3.73 earnings per share for the current fiscal year.

Insider Activity

In other LivaNova news, Director Francesco Bianchi sold 1,800 shares of the business’s stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $75.75, for a total value of $136,350.00. Following the transaction, the director directly owned 7,228 shares in the company, valued at $547,521. The trade was a 19.94% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.35% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On LivaNova

A number of institutional investors have recently added to or reduced their stakes in LIVN. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of LivaNova by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 35,497 shares of the company’s stock worth $1,394,000 after purchasing an additional 1,360 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in shares of LivaNova by 4.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 814,974 shares of the company’s stock worth $32,012,000 after purchasing an additional 36,094 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of LivaNova by 10.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 168,863 shares of the company’s stock worth $6,633,000 after purchasing an additional 15,405 shares in the last quarter. Intech Investment Management LLC increased its position in shares of LivaNova by 19.6% during the 1st quarter. Intech Investment Management LLC now owns 43,879 shares of the company’s stock valued at $1,724,000 after purchasing an additional 7,195 shares during the last quarter. Finally, Strs Ohio purchased a new position in shares of LivaNova during the 1st quarter valued at about $130,000. 97.64% of the stock is currently owned by institutional investors.

About LivaNova

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.